Indian Drug Companies Urge Government to Stop Evergreening Tactics

Law360, New York (November 1, 2003, 12:00 AM EST) -- India's pharmaceutical companies urged the government not to reopen issues such as compulsory licensing and Bolar exception as it prepares to amend the Patent Act, the Economic Times of India reported.

These provisions were incorporated into an amendment passed last year, and it would be too early to assess their efficiency now, the industry claims.

The Indian government, which is drafting a third amendment to the act, has said the revisions would be "substantive" in nature, according to the Economic Times.

The Indian Pharmaceutical Alliance (IPA)...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.